Mount Sinai School of Medicine -- an institution committed to accelerating scientific discovery and translating those discoveries into better diagnostic tools and treatment -- is excited to partner with the YAI/NIPD Network, comprised of seven not-for-profit agencies serving individuals with developmental and learning disabilities for nearly 50 years. The partnership will bring the highest levels of quality care and access to state-of-the-art evaluation, diagnosis, treatment and services for patients with ASD.
"The goal of this endeavor is to create a premier autism center in New York. Mount Sinai's expertise in research and evaluation and the YAI/NIPD's Network's capacity and reputation in services and treatment will create a unique program," said Kenneth L. Davis, MD, President and CEO, The Mount Sinai Medical Center and Dean, Mount Sinai School of Medicine. "We believe this combined venture will serve as a model for other programs throughout the country."
"The need for the provision of treatment and services for people with Autism Spectrum Disorder has never been greater," said Joel M. Levy, CEO, YAI/NIPD. "We are certain that the YAI/NIPD Network's partnership with Mount Sinai School of Medicine and The Seaver and New York Autism Center for Excellence will play a pivotal role in addressing this pressing need."
ASD affects more children today than diabetes or Down syndrome. It is characterized by varying degrees of impairment in communication skills, social interactions and repetitive patterns of behavior. In some children, hints of future problems may be apparent fro
Contact: Mount Sinai Press Office
The Mount Sinai Hospital / Mount Sinai School of Medicine